Bolt Biotherapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Bolt Biotherapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2024.
  • Bolt Biotherapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.2M, a 3.36% increase year-over-year.
  • Bolt Biotherapeutics, Inc. annual Operating Lease, Payments for 2023 was $4.73M, a 1.42% increase from 2022.
  • Bolt Biotherapeutics, Inc. annual Operating Lease, Payments for 2022 was $4.66M, a 49.7% increase from 2021.
  • Bolt Biotherapeutics, Inc. annual Operating Lease, Payments for 2021 was $3.11M, a 24.9% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.2M +$39K +3.36% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $1.16M -$23K -1.94% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $1.19M +$1.01M +589% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $172K -$1.22M -87.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $1.39M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.